Clinical Trial Update: Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 feasibility trial evaluated whether 2000 IU per day of vitamin D could aid primary prevention of Type 1 diabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Canadian Diabetes Association | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED